CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Medical Coverage Policy Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux

Policy governs coverage determination for laparoscopic implantation (insertion only) of magnetic esophageal sphincter augmentation devices (eg, LINX) to treat gastroesophageal reflux disease for Medicare Advantage and Commercial products.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyMedical Coverage Policy Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux

Policy CodePolicy N/A

Change TypeClarified

Effective DateJan 1, 2017

Next Review Date

Key ActionVerify member-specific benefits and coverage limitations in the applicable Benefit Booklet, Evidence of Coverage or Subscriber Agreement prior to performing the procedure.

SourceLink

POLICY UPDATE CHANGES

Policy states device insertion is not covered for Medicare Advantage and not medically necessary for Commercial products due to insufficient evidence.

2Payer coverage determinations (Medicare Advantage, Commercial)

1Policy scope (insertion only)

Coverage Summary

This policy governs coverage for the laparoscopic implantation (insertion only) of magnetic esophageal sphincter augmentation devices (eg, the LINX Reflux Management System) to treat gastroesophageal reflux disease (GERD). The LINX device is a small flexible band composed of interlinked titanium beads with magnetic cores that is placed around the gastroesophageal junction; the magnetic attraction between the beads is intended to augment the lower esophageal sphincter to reduce reflux without compressing the esophageal wall. The policy applies only to device insertion; removal is addressed by a related policy.

Overall coverage stance: Insertion of magnetic esophageal sphincter augmentation (eg, LINX) is not covered for Medicare Advantage and is considered not medically necessary for Commercial products. The policy cites FDA premarket approval for the LINX device but concludes the evidence base—primarily single-arm trials and observational comparative studies with limited randomized data—is insufficient to determine net health benefit, supporting the noncoverage stance.

Coverage / Medical Necessity Determinations

Medicare Advantage Plans Coverage Determination

Coverage statement:

Magnetic esophageal sphincter augmentation to treat gastroesophageal reflux disease is not covered as the evidence is insufficient to determine the effects of the technology on health outcomes

Medicare Advantage Plans Coverage Determination - coding

Not covered procedure description: Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed is not covered for Medicare Advantage Plans

Policy scope note

Insertion only: This policy is for the insertion only: removal of the devices is governed by the related policy 'Removal of Implantable Devices'

Commercial Products Coverage Determination

Coverage statement:

Magnetic esophageal sphincter augmentation to treat gastroesophageal reflux disease is not medically necessary as the evidence is insufficient to determine the effects of the technology on health outcomes

Commercial Products Coverage Determination - coding

Not medically necessary procedure description: Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed is not medically necessary for Commercial Products

Policy scope note

Insertion only: This policy is for the insertion only: removal of the devices is governed by the related policy 'Removal of Implantable Devices'

Scope / Insertion vs Removal

Policy scope note:

Insertion only scope: This policy is for the insertion only of the magnetic esophageal sphincter augmentation device; removal of the device is governed by the related policy 'Removal of Implantable Devices'

Not Covered / Not Medically Necessary

Not-covered stance: Magnetic esophageal sphincter augmentation to treat GERD is not covered for Medicare Advantage because the evidence is insufficient to determine the effects of the technology on health outcomes.

Not medically necessary stance for Commercial products: Magnetic esophageal sphincter augmentation to treat GERD is not medically necessary for Commercial products for the same reason—insufficient evidence to determine effects on health outcomes. The policy explicitly applies to insertion only; removal is governed separately.

Not covered / not medically necessary procedure descriptionmixedNot Covered

Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed

Provider Actions / Billing Impact

Documentation Required

Refer to Benefit Booklet / Evidence of Coverage

Verify member-specific benefits and coverage limitations in the applicable Benefit Booklet, Evidence of Coverage, or Subscriber Agreement prior to performing the procedure.

Billing Rule

Insertion excluded for Medicare Advantage and Commercial

Claims for laparoscopic placement of a magnetic sphincter augmentation device are considered not covered for Medicare Advantage members and not medically necessary for Commercial products; billers should expect denial for the insertion procedure.

Affected procedure: Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (eg, magnetic band), including cruroplasty when performed
Denial expectation: Billers should expect denial for the insertion procedure (not covered for Medicare Advantage; not medically necessary for Commercial products)

Background & Evidence Summary

The LINX Reflux Management System is composed of a small flexible band of 10 to 18 interlinked titanium beads with magnetic cores placed laparoscopically around the esophagus at the gastroesophageal junction. The magnetic attraction between beads is intended to augment the lower esophageal sphincter, allowing temporary separation of beads during swallowing to permit passage of food or liquids.

Evidence submitted for the device includes manufacturer-sponsored single-arm trials and prospective/retrospective observational studies; randomized data comparing MSA with fundoplication or with medical therapy are limited or in progress, and the policy considers this body of evidence insufficient to determine effects on health outcomes.

Common adverse events reported with the device include dysphagia and odynophagia; the device can erode and may require removal (laparoscopic explantation), and other device-related complications have been described in the literature and FDA materials.

Regulatory & Evidence Summary

Revision History

2017-01-01policy_effective

Policy effective date: 01/01/2017 (Medical Coverage Policy Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux).

2024-10-16policy_reviewLatest

Policy last reviewed: 10/16/2024.

coverage_determinationLatest

Medicare Advantage Plans: Magnetic esophageal sphincter augmentation to treat gastroesophageal reflux disease is not covered as the evidence is insufficient to determine the effects of the technology on health outcomes.

coverage_determinationLatest

Commercial Products: Magnetic esophageal sphincter augmentation to treat gastroesophageal reflux disease is not medically necessary as the evidence is insufficient to determine the effects of the technology on health outcomes.

scope_clarificationLatest

Policy applies to insertion only; removal of the device is governed by a related policy ('Removal of Implantable Devices').

policy_changeLatest

Policy states device insertion is not covered for Medicare Advantage and not medically necessary for Commercial products due to insufficient evidence. (Applies only to insertion; removal handled by related policy.)

coding_noteLatest

Procedure not covered / not medically necessary: Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed.